[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Naveris_inc Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1849230415.png) @Naveris_inc Naveris, Inc.

Naveris, Inc. posts on X about  the most. They currently have XXX followers and X posts still getting attention that total X engagements in the last XX hours.

### Engagements: X [#](/creator/twitter::1849230415/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1849230415/c:line/m:interactions.svg)

- X Months XX +11%

### Mentions: X [#](/creator/twitter::1849230415/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1849230415/c:line/m:posts_active.svg)


### Followers: XXX [#](/creator/twitter::1849230415/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1849230415/c:line/m:followers.svg)

- X Months XXX +7%

### CreatorRank: undefined [#](/creator/twitter::1849230415/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1849230415/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1849230415/influence)
---
### Top Social Posts [#](/creator/twitter::1849230415/posts)
---
Top posts by engagements in the last XX hours

"Naveris executive chairman founder and chief science & technology officer Piyush Gupta PhD joins a roundtable discussion on Evolving Technologies for Molecular Residual Disease Testing in Solid Tumors Perspectives on Platforms and Clinical Utility sponsored by @QIAGEN. On October XX at 12:00pm Eastern Dr. Gupta and other clinical oncology and biotech experts will discuss evolving best practices for MRD testing in solid tumors reflect on clinical questions that future studies will need to answer and explore how different technologies like dPCR and next-gen sequencing may be better 'fit for"  
[X Link](https://x.com/Naveris_inc/status/1979272144556114091) [@Naveris_inc](/creator/x/Naveris_inc) 2025-10-17T19:43Z XXX followers, XX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Naveris_inc Naveris, Inc.

Naveris, Inc. posts on X about the most. They currently have XXX followers and X posts still getting attention that total X engagements in the last XX hours.

Engagements: X #

X Months XX +11%

Mentions: X #

Followers: XXX #

X Months XXX +7%

CreatorRank: undefined #

Social Influence #

Top Social Posts #

Top posts by engagements in the last XX hours

"Naveris executive chairman founder and chief science & technology officer Piyush Gupta PhD joins a roundtable discussion on Evolving Technologies for Molecular Residual Disease Testing in Solid Tumors Perspectives on Platforms and Clinical Utility sponsored by @QIAGEN. On October XX at 12:00pm Eastern Dr. Gupta and other clinical oncology and biotech experts will discuss evolving best practices for MRD testing in solid tumors reflect on clinical questions that future studies will need to answer and explore how different technologies like dPCR and next-gen sequencing may be better 'fit for"
X Link @Naveris_inc 2025-10-17T19:43Z XXX followers, XX engagements